BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
24 avr. 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
24 avr. 2024 07h00 HE
|
atai Life Sciences
The BPL-003 Phase 2a trial is an open-label study investigating BPL-003 as both monotherapy and adjunctive to SSRIs in patients with Treatment Resistant Depression.Initial results from the recently...
First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients
24 avr. 2024 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Active Pharmaceutical Ingredient Market Trends Signal Growth Towards USD 446.6 Billion by 2032 With CAGR AT 6.4%
23 avr. 2024 12h43 HE
|
Dimension Market Research
New York, April 23, 2024 (GLOBE NEWSWIRE) -- Overview According to Dimension Market Research, The Global Active Pharmaceuticals Ingredient Market size was valued USD 249.0 billion in 2023 and it...
Keiretsu Forum Regions Demonstrate Investment Stability Amidst Industry-Wide Downturns
23 avr. 2024 07h29 HE
|
Keiretsu Forum Mid-Atlantic
In 2023, Keiretsu Forum MA-SE-TX region’s curated investment portfolio maintained a confident stance within an otherwise retreating investment ecosystem.
Biotech Seeds Global Strategic Business Report 2024: A US$119.2 Billion Market by 2030, growing at a CAGR of 7.3% During 2023-2030
23 avr. 2024 03h17 HE
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Biotech Seeds - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Biotech Seeds estimated...
Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy
19 avr. 2024 07h13 HE
|
Ocugen
MALVERN, Pa., April 19, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...
Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer
19 avr. 2024 04h08 HE
|
Amarna Therapeutics
Leiden, The Netherlands, 19 April 2024 – Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, including Type...
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024
18 avr. 2024 16h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
18 avr. 2024 16h05 HE
|
Lumos Pharma, Inc.
AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD)...